Dr. Reddy's Laboratories reports 36% rise in Q4 consolidated net profit

07 May 2024 Evaluate

Dr. Reddy's Laboratories has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 53.90% rise in its net profit at Rs 1,034.80 crore for the quarter under review as compared to Rs 672.40 crore for the same quarter in the previous year. Total income of the company increased by 13.89% at Rs 5,317.50 crore for Q4FY24 as compared Rs 4,668.80 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 36.42% rise in its net profit at Rs 1,309.80 crore for fourth quarter ended March 31, 2024 as compared to Rs 960.10 crore for the same quarter in the previous year. Total income of the company increased by 13.29% at Rs 7,311.30 crore for Q4FY24 as compared Rs 6,453.70 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 66.18% rise in net profit at Rs 4,342.00 crore as compared to Rs 2,612.80 crore for the previous year. Total income of the company increased by 15.91% at Rs 20,346.10 crore for year under review as compared to Rs 17,553.80 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 23.75% rise in its net profit at Rs 5,577.90 crore as compared to Rs 4,507.30 crore for the previous year. Total income of the company increased by 12.36% at Rs 28,905.40 crore for year under review as compared to Rs 25,725.20 crore for year ended March 31, 2023.


Dr. Reddys Lab Share Price

5812.50 13.25 (0.23%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.